COMPARISON OF SERUM CXCL13 LEVELS BETWEEN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

被引：0
|
作者：
Yildirim, D. [1 ]
Vasi, I. [1 ]
Baykul, M. [2 ]
Gulengul, M. [3 ]
Edek, Y. [3 ]
Kucuk, H. [1 ]
Karadeniz, H. [1 ]
Adisen, E. [3 ]
Erden, A. [1 ]
Tufan, A. [1 ]
Goker, B. [1 ]
Nas, K. [4 ]
Ozturk, M. A. [1 ]
机构：
[1] Gazi Univ, Rheumatol, Fac Med, Ankara, Turkiye
[2] Sakarya Univ, Internal Med, Educ & Res Hosp, Sakarya, Turkiye
[3] Gazi Univ, Dermatol, Fac Med, Ankara, Turkiye
[4] Sakarya Univ, Rheumatol, Educ & Res Hosp, Sakarya, Turkiye
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Prognostic factors; Cytokines and chemokines; Psoriatic arthritis; BIOMARKER;
D O I：
10.1136/annrheumdis-2023-eular.2017
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB1162
引用
收藏
页码：1811 / 1812
页数：2
相关论文
共 50 条
  • [1] EVALUATION OF CXCL13 SERUM LEVELS IN A COHORT OF PATIENTS WITH PERIPHERAL PSORIATIC ARTHRITIS IN COMPARISON WITH RHEUMATOID ARTHRITIS.
    Piantoni, S.
    Angeli, F.
    Regola, F.
    Valtellini, L.
    Franceschini, F.
    Airo, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1841 - 1841
  • [2] CSF and serum levels of CXCL13 in MS and NMO
    Alvarez, E.
    Piccio, L.
    Mikesell, R. J.
    Klawiter, E. C.
    Parks, B. J.
    Naismith, R. T.
    Cross, A. H.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S502 - S503
  • [3] SERUM LEVELS OF CXCL13 ARE INCREASED IN UNTREATED PATIENTS WITH RHEUMATOID ARTHRITIS FROM THE FIRST WEEKS OF DISEASE DEVELOPMENT
    Moura, Rita A.
    Canhao, Helena
    Polido-Pereira, Joaquim
    Navalho, Marcio
    Leandro, Maria J.
    Cambridge, Geraldine
    Fonseca, Joao Eurico
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : A32 - A33
  • [4] Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple Sclerosis
    Fissolo, Nicolas
    Pappolla, Agustin
    Rio, Jordi
    Villar, Luisa M. M.
    Perez-Hoyos, Santiago
    Sanchez, Alex
    Gutierrez, Lucia
    Montalban, Xavier
    Comabella, Manuel
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (01):
  • [5] SERUM LEVELS OF CXCL13 ARE INCREASED IN UNTREATED PATIENTS WITH RHEUMATOID ARTHRITIS FROM THE FIRST WEEKS OF DISEASE DEVELOPMENT
    Moura, R. A.
    Canhaeo, H.
    Polido-Pereira, J.
    Navalho, M.
    Leandro, M. J.
    Cambridge, G.
    Fonseca, J. E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 832 - 832
  • [6] Serum CXCL10 is Elevated in Psoriasis Patients Prior to Psoriatic Arthritis Onset
    Pollock, Remy
    Abji, Fatima
    Shakil, Husain
    Liang, Kun
    Chandran, Vinod
    Gladman, Dafna
    [J]. JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1331 - 1331
  • [7] Serum levels of CXCL13 are elevated in active multiple sclerosis
    Festa, Eugene D.
    Hankiewicz, Karolina
    Kim, Soyeon
    Skurnick, Joan
    Wolansky, Leo J.
    Cook, Stuart D.
    Cadavid, Diego
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (11) : 1271 - 1279
  • [8] Clinical significance of serum B cell chemokine (CXCL13) in early rheumatoid arthritis patients
    Allam, Shadia, I
    Sallam, Rehab A.
    Elghannam, Doaa M.
    El-Ghaweet, Atif, I
    [J]. EGYPTIAN RHEUMATOLOGIST, 2019, 41 (01): : 11 - 14
  • [9] SERUM LEVELS OF CXCL13 REFINE THE PREDICTIVE ABILITY OF AUTOANTIBODIES TO IDENTIFY UNSTABLE REMISSION IN EARLY RHEUMATOID ARTHRITIS
    Bugatti, S.
    Manzo, A.
    Vitolo, B.
    Benaglio, F.
    Caporali, R.
    Montecucco, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 696 - 696
  • [10] CXCL-13 serum levels in patients with rheumatoid arthritis treated with abatacept
    Masneri, S.
    Piantoni, S.
    Galoppini, G.
    Regola, F.
    Nalli, C.
    Bazzani, C.
    Franceschini, F.
    Airo, P.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (11) : 2103 - 2108
12345